Australia markets open in 6 hours 14 minutes

Dare Bioscience Inc (1221.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.3905+0.0185 (+4.97%)
At close: 08:06AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,817
2,808
10,000
0
0
Operating expenses
Research development
19,846
21,538
30,042
30,618
20,769
Selling general and administrative
11,451
12,110
11,243
8,451
6,633
Total operating expenses
31,397
33,748
41,385
39,069
27,402
Operating income or loss
-28,580
-30,940
-31,385
-39,069
-27,402
Total other income/expenses net
-294.542
778.489
437.75
372.407
1.514
Income before tax
-28,874
-30,161
-30,948
-38,696
-27,401
Income from continuing operations
-28,874
-30,161
-30,948
-38,696
-27,401
Net income
-28,874
-30,161
-30,948
-38,696
-27,401
Net income available to common shareholders
-28,874
-30,161
-30,948
-38,696
-27,408
Basic EPS
-0.48
-0.35
-0.37
-0.63
-0.91
Diluted EPS
-0.48
-0.35
-0.37
-0.63
-0.91
Basic average shares
85,823
87,304
84,572
61,154
30,091
Diluted average shares
85,823
87,304
84,572
61,154
30,091